Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic (Q40050028)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 November 2007
edit
Language Label Description Also known as
English
Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic
scientific article published on 20 November 2007

    Statements

    Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit